Mark Alan Goldberg - Mar 31, 2022 Form 4/A - Amendment Insider Report for ImmunoGen, Inc. (IMGN)

Role
Director
Signature
/s/ Renee Lentini, attorney in fact
Stock symbol
IMGN
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/20/2022, 05:38 PM
Date Of Original Report
Apr 4, 2022
Previous filing
Mar 7, 2022
Next filing
May 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Deferred Share Unit Award $0 +3.55K +2.7% $0.00 135K Mar 31, 2022 Common Stock 3.55K $0.00 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
F2 The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
F3 The deferred share units vest upon issuance.
F4 Due to clerical error, this amendment to Form 4 is being filed to correct the number of DSUs awarded on March 31, 2022 and the number of DSUs beneficially owned following the reported transaction.